Viewing StudyNCT00255008



Ignite Creation Date: 2024-05-05 @ 12:07 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00255008
Status: TERMINATED
Last Update Posted: 2017-04-06
First Post: 2005-11-15

Brief Title: Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients A Comparison of Race and Genotype on Treatment Outcome Study P04212
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Organization Data

Organization: Merck Sharp Dohme LLC
Class: INDUSTRY
Study ID: P04212
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Merck Sharp Dohme LLC
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators